Navigation Links
Landauer Elects Board Member Michael T. Leatherman as Interim Chief Financial Officer

GLENWOOD, Ill., Aug. 25, 2011 /PRNewswire/ -- Landauer, Inc. (NYSE: LDR) today announced that its Board of Directors has appointed, Michael T. Leatherman, as the Company's Interim Chief Financial Officer, as well as its acting principal financial officer and principal accounting officer, effective September 9, 2011. Leatherman succeeds Jonathon Singer, who had served as CFO since October 2006 and has left the Company in order to accept the chief financial officer position with Sagent Pharmaceuticals, Inc.

"Mike has worked with Landauer since 2003, and he has been a Board member for the last three years. He has deep knowledge and history with the Company, understands our core radiation monitoring business and has been instrumental in shaping our growth strategy initiatives. The Board and I are confident that Mike will provide strong continuity as CFO and Treasurer as we search for a permanent Chief Financial Officer," said Bill Saxelby, President and Chief Executive Officer of Landauer, Inc.

Mr. Leatherman, age 58, has been a Director of the Company since 2008.  Since 2000, Mr. Leatherman has served as an Independent Consultant, primarily to the information technology industry.  Mr. Leatherman is a Certified Public Accountant and previously served as the Chief Financial Officer of Wallace Computer Services, Inc., which prior to its acquisition by Moore Corporation was a NYSE-listed company.

During his term as Interim Chief Financial Officer, Mr. Leatherman will continue to serve as a director of the Company, but will cease his service as a member of the Audit Committee and Compensation Committee of the Company's Board of Directors.  The Company intends to conduct an executive search for a permanent Chief Financial Officer to replace Mr. Singer.

"The Board of Directors thanks Jon for his contributions to the Company.  He played an important role with Landauer during his time with the Company.  We wish him well in his new endeavor," noted Robert Cronin, Chairman of the Board of Directors.

About Landauer, Inc.

Landauer is a leading global provider of technical and analytical services to determine occupational and environmental radiation exposure and is the leading domestic provider of outsourced medical physics services. For more than 50 years, the Company has provided complete radiation dosimetry services to hospitals, medical and dental offices, universities, national laboratories, nuclear facilities and other industries in which radiation poses a potential threat to employees. Landauer's services include the manufacture of various types of radiation detection monitors, the distribution and collection of the monitors to and from customers, and the analysis and reporting of exposure findings. The Company provides its dosimetry services to approximately 1.6 million individuals globally. In addition, through its Global Physics Solutions subsidiary, the Company provides therapeutic and imaging physics services to the medical physics community.

SOURCE Landauer, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Landauer, Inc. Reports Fiscal 2011 Third Quarter Results
2. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Third Quarter 2011 Results
3. Landauer, Inc. Declares Regular Cash Dividend
4. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Second Quarter 2011 Results
5. Landauer, Inc. Declares Regular Cash Dividend
6. Landauer, Inc. Sets Date and Time for Announcement of Fiscal First Quarter 2011 Results
7. Landauer, Inc. Declares Regular Cash Dividend
8. Landauer, Inc. Sets Date and Time for Announcement of Fiscal First Quarter 2010 Results
9. Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results
10. Landauer Acquires Global Physics Solutions, Inc. as Platform to Expand Into Medical Physics Services Market
11. InspireMD Elects Two New Board Members
Post Your Comments:
(Date:11/27/2015)... DUBLIN , Nov. 27, 2015 Research ... of the "Global Intrauterine Devices Market 2015-2019" ... --> In this report, the author ... intrauterine devices market for 2015-2019. To calculate the market ... of following type of products: Hormonal IUDs and copper ...
(Date:11/26/2015)... UTRECHT , Países Bajos, November 26, 2015 /PRNewswire/ ... con la terapia fotodinámica de Bremachlorin para el cáncer ... combina la inmunoterapia con la terapia fotodinámica de Bremachlorin ... Un nuevo enfoque combina la inmunoterapia con la ...   Clinical Cancer Research . --> ...
(Date:11/26/2015)... November 26, 2015 ... nieuwe aanpak combineert immunotherapie met Bremachlorin-photodynamische therapie ... ) --> ... (Photo: ) ... Medisch Centrum (LUMC) blijkt ...
Breaking Medicine Technology:
(Date:11/30/2015)... , ... November 30, 2015 , ... GKhair & Tibolli ... the San Juan Beauty Show held on November 8th and 9th at the Puerto ... media personalities, hair artists, renowned beauticians and top of the line fashion journalists. The ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... provider of enterprise Time and Attendance/Workforce Management cloud-based solutions, announced today that ... Program with competencies in the Application Development, demonstrating a “best-in-class” ability and ...
(Date:11/30/2015)... , ... November 30, 2015 ... ... Inc. are pleased to announce their strategic partnership at the Radiological Society ... Transcription Service, Inc., and Winscribe, global providers of cutting-edge dictation and speech-enabled ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... product dealer. Joining more than 30 HealthPostures’ dealers located throughout the United States, ... increase the number of corporate, industrial, manufacturing and government workers and organizational leaders ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... patented products, announces the Unstoppable Swappables, a household invention that provides an economical ... $2 billion a year and is growing at 2.6%," says Scott Cooper, CEO ...
Breaking Medicine News(10 mins):